The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaracal Gold Regulatory News (GCAT)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Caracal Gold (GCAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
GCAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings

31 Aug 2021 08:00

RNS Number : 1911K
Caracal Gold PLC
31 August 2021
 

Caracal Gold plc / EPIC: GCAT / Market: Main / Sector: Mining

31 August 2021

Caracal Gold plc ('Caracal' or the 'Company')

First Day of Dealings

 

Caracal Gold plc, the gold producer with operations in East Africa, is pleased to announce that at 08:00 today its ordinary shares will commence trading on the Main Market for listed securities of the London Stock Exchange plc ('LSE') under the ticker GCAT ('Readmission') with contemporaneous dual listing on the Frankfurt Stock Exchange (WKN: A2AM01 and Ticker: FSE: 6IK). As part of the Readmission process, the Company has raised gross proceeds of approximately £5,493,885 through the issue of 638,951,276 Placing Shares completed in two rounds at a placing price of £0.01 per share, implying a market capitalisation of circa £14.5 million on Readmission.

 

INVESTMENT DRIVERS

· Cash generative and substantially de-risked

o Forecast low AISC-costs and strong operating margins from gold sales at 100% owned Kilimapesa Gold Mine.

· Defined growth strategy

o Phased growth plans and organic development at Kilimapesa as well as exciting acquisition opportunities under review.

· Robust market

o Gold market driven by several factors including financial and geopolitical uncertainties and low interest rates.

· Proven team

o Board and Management with track records in successfully developing and operating mining projects throughout Africa.

 

Robbie McCrae, CEO of Caracal, said, "We are delighted to commence trading on both the London and Frankfurt Stock Exchanges; with this milestone reached, we have a very exciting opportunity to continue to expand our mining operations and solidify our position as an emerging East African focused gold producer. To this end, we aim to rapidly increase production to +50,000oz p.a. and build a JORC compliant resource base of +3Moz within 12-18 months. We have already started an optimisation strategy at the Kilimapesa Gold Mine, where there is significant expansion potential and ability to increase gold production to 25,000oz p.a. and the resource to +2Moz. We also aim to utilise our experienced team to acquire other complementary and strategically located gold mine and development projects in East Africa.

 

"The successful c.£5.5 million fundraising, which saw key UK and European institutions and retail investors join our share register, highlights our compelling investment opportunity: a producing asset in Kilimapesa; strong gold market dynamics; and a team with a track record of delivery in the gold space. Given the high volume of activity and steady stream of news ahead for the Company, I am confident that we will deliver value to shareholders and look forward to having a regular dialogue with them."

 

DETAILS

The Company aims to build a position as an emerging East African focused gold producer with a clear path to grow production and resources both organically and through strategic acquisitions. Following Readmission, it aims to rapidly increase production to +50,000ozs per annum ('p.a.') and build a JORC compliant resource base of +3Moz within 12-18 months from listing. 

 

To this end, a phased mine optimisation strategy at the Company's newly acquired Kilimapesa Gold Mine is already advancing, where there is significant expansion potential and ability to increase gold production to 25,000oz p.a. and the resource to +2Moz.

 

Additionally, the Company aims to utilise its experienced team to acquire other complementary and strategically located gold mine and development projects in East Africa; several assets are under review.

 

To enhance its international profile and ensure the Company will be well positioned to engage with a broad spectrum of UK, European and African-based funds, institutions, and investors, the Company also aims to undertake a Nairobi cross-listing via an introduction of the Company's shares to the Growth Enterprise Market Segment ("GEMS") of the Nairobi Securities Exchange ("NSE") (the "NSE Listing"). Faida Investment Bank Limited ('Faida'), headquartered in Nairobi, Kenya, is its financial adviser and joint broker, in relation to this. Faida is a market leader in the Kenyan securities and capital markets and works in joint venture with the Company's joint broker, VSA Capital Ltd, for the benefit of corporate clients.

 

Placing & Use of Proceeds

The Company has raised gross proceeds of approximately £5,493,885 through the issue of 638,951,276 Placing Shares. The placing price has been completed in two rounds, comprising first round commitments of £2,686,885 and second round commitments of £2,807,000 that was completed at a placing price of £0.01 per share.

 

The net proceeds from the Placing will be used to advance the development strategy at Kilimapesa and applied to pay professional fees incurred in relation to the transaction and for general working capital purposes.

 

Further information on the Company, including the Prospectus published in conjunction with Readmission, can be found on the Company's website: https://caracalgold.com.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

ENDS

 

For further information visit https://caracalgold.com or contact the following:

 

Caracal Gold plc

Gerard Kisbey-Green

Jason Brewer

info@caracalgold.com

Novum Securities Ltd

Joint Broker

Colin Rowbury

crowbury@novumsecurities.com

 

VSA Capital Ltd

Financial Adviser and Joint Broker

Andrew Raca / James Deathe

ipo@vsacapital.com

St Brides Partners Ltd

Financial PR

Isabel de Salis

info@stbridespartners.co.uk

DGWA, the German Institute for Asset and

Equity Allocation and Valuation

European Investor and Corporate

Relations Advisor

Stefan Müller / Katharina Löckinger 

info@dgwa.org

 

 

Notes

Caracal Gold plc is an emerging East African focused gold producer with a clear path to grow production and resources both organically and through strategic acquisitions. Its aim is to rapidly increase production to +50,000ozs p.a. and build a JORC compliant resource base of +3Moz within 12-18 months from its listing in August 2021. To this end, it is currently progressing a well-defined mine optimisation strategy at its 100% owned Kilimapesa Gold Mine, where there is significant expansion potential and ability to increase gold production to 25,000oz p.a. and the resource to +2Moz. Notably, the mine has strong community support and local stakeholder engagement. Additionally, its experienced team, with proven track record in successfully developing and operating mining projects throughout Africa, is reviewing other complementary and strategically located gold mine and development projects in East Africa.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGFRKMRGMZG
Date   Source Headline
26th Mar 20249:08 amRNSSubscription to raise £780,000
7th Mar 202410:31 amRNSUpdate
23rd Jan 20249:30 amRNSSubscription to raise £140,000
19th Jan 20245:46 pmRNSFinancing Update
14th Nov 20237:00 amRNS$1.55m Debt Funding Update
1st Nov 20237:00 amRNSDelay to Publication of Annual Report and Accounts
26th Oct 20237:00 amRNSMine Plan for Kilimapesa expansion
24th Oct 20233:48 pmRNSDelay to Publication of Annual Report and Accounts
9th Oct 20238:32 amRNSResults of General Meeting
29th Sep 202311:16 amRNSSubscription raises £92,750
11th Sep 20237:00 amRNSNotice of General Meeting
4th Aug 20237:00 amRNSCorporate Update and Q2 2023
19th Jul 20239:29 amRNSResignation of Non-Executive Director
13th Jul 20233:55 pmRNSFinancing and group reserves and resources update
22nd Jun 202312:22 pmRNSTanzania Completion Update
12th Jun 20234:06 pmRNSCorporate Governance and Board Changes Update
7th Jun 202310:14 amRNSTR-1: Notification of Major Holdings
16th May 20234:30 pmRNSCorrection to terms of Mill End Facility
16th May 202310:51 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSCorporate Update and Q1 2023 Operations Summary
12th May 20233:24 pmRNSSettlement of Loan Facility and PDMR Shareholding
26th Apr 20237:00 amRNSChairman Confirmation & Governance Review Update
24th Apr 20239:20 amRNSStatement re. Mining and Ore Processing Results
31st Mar 20232:32 pmRNSInterim results 31 December 2022
30th Mar 20237:00 amRNSHigh Grade Zone on Kilimapesa Hill
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
21st Mar 20237:00 amRNSHigh Grade Zone on Kilimapesa Hill
7th Mar 202310:37 amRNSTR-1: Notification
20th Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20234:40 pmRNSSecond Price Monitoring Extn
16th Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSAdditional Financing Secured & Corporate Update
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
24th Jan 20232:00 pmRNSPrice Monitoring Extension
24th Jan 20239:05 amRNSSecond Price Monitoring Extn
24th Jan 20239:00 amRNSPrice Monitoring Extension
23rd Jan 20234:45 pmRNSCorporate Update, Q3 &Q4 2022 Operations Summary
23rd Jan 202311:43 amRNSResult of AGM
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 20234:30 pmRNSBoard Change
10th Jan 20239:05 amRNSSecond Price Monitoring Extn
10th Jan 20239:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSFinancing Update
21st Dec 20229:00 amRNSPrice Monitoring Extension
21st Dec 20227:00 amRNSScoping Study Delivers Robust Project Economics
13th Dec 20222:05 pmRNSSecond Price Monitoring Extn
13th Dec 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.